Clinical Trial Update: The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial update describing the safety and preliminary efficacy evaluation of ALT001 in patients with the cerebellar subtype of Multiple System Atrophy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• ALT001

Snippet

Sponsor: yilong Wang | Conditions: Multiple System Atrophy - Cerebellar Subtype (MSA-C) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING